Praxis Precision Medicines, Inc. (PRAX)

Healthcare · Biotechnology · NASDAQ

Praxis Precision Medicines, Inc. (PRAX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $10.06B and a free-cash-flow yield of -3.1%. Over the most recent reported fiscal year, revenue declined 100.0%.

Market cap	$10.06B
Trailing P/E	—
FCF yield	-3.1%
Revenue growth (YoY)	-100.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live PRAX data on Nama Insights →